Friday 27 April 2012

Hiv Persistence-Hiv Functional-Hiv Research-HIV

Dr. Robert C Gallo Interview: HIV Research at a Crossroad?

hiv-reservoir.net (Jan. 13, 2011): "Alain Lafeuillade: it looks like the terms ‘HIV sterilizing cure’ and ‘HIV functional cure’ are no longer ‘dirty’ words for scientists. What is the main gap in our knowledge about HIV persistence that should be resolved before we can envision new strategies to reach these goals?"Robert C. Gallo:  The answer is clearly demonstrating the precise cell types that are the source of persisting HIV.  This means cells that go beyond the common memory T cells that currently are chiefly studied, and demonstrating that by so-called “purging” these cells by activation mechanisms will lead to death of these cells.  At the moment this is the assumption." read more..

Sustainable Development-Humanitarian Services-Honorary Citizenship-Royal Society Report

Africa: Sustainable Development Means Tackling Childbirth Rates - Report

[SciDev.Net] London - Least developed countries (LDCs) must improve women's access to education and family planning if they are to achieve sustainable development, according to recommendations in a Royal Society report, People and the Planet, launched this week (26 April). read more..


Ethiopia: Meles Vests Honorary Citizenship on Dr. Catherine Hamlin

[ENA] Addis Ababa - Prime Minister Meles Zenawi vested an honorary citizenship of Ethiopia on Founder and Owner of the Fistula Hospital, Dr Catherine Hamlin in recognition of her outstanding humanitarian services she provided to fistula patients. read more..

Experimental Drug Avanafil-Erectile Dysfunction-Viagra

Avanafil: Do We Need Another Viagra?

The Erectile Dysfunction marketplace could get its first new entry in almost a decade with the experimental drug Avanafil, a faster-acting pill in the same class as Viagra, Levitra and Cialis, reportedly with fewer side effects. But do we really need another Viagra? “No, we don’t... read more..

source:yahoo.com

Complications Of Pregnancy-Maternal Health-Ruptured Uterus-Maternal Death-Childbirth

Africa: MDG 5 - Africa Makes Haste Slowly On Maternal Health

[Vanguard] ANOTHER woman just died in Childbirth. Sentenced to death by Pregnancy! One dies every 10 minutes. For each maternal death in the world's most populous black nation, there are at least two dozen survivors, but they suffer from short or long-term disabilities including obstetric fistulae, ruptured uterus and paralysis and other physical damage caused by complications of pregnancy or childbirth. Each year, millions of children are left motherless. Over the next two years, these children are three to 10 times read more..

Monday 23 April 2012

Difficulty Sleeping-Infant Behavior-Deadly Disease-Encephalitis-Sleep Clinic

Infant Behavior, Cry And Sleep Clinic: Research Shows Efficacy Of Treatment Model

Having a new baby brings much joy to a new Family.But for a family whose baby cries for hours on end, fusses through feedings, or has difficulty sleeping, the joy may be overshadowed by feelings of helplessness and frustration.The treatment of that infant - and that family - will impact the parent-child relationship for years to come... read more..


In Rare, Often Undiagnosed Form Of Encephalitis, Early Treatment Improves Outcomes

A mysterious, difficult-to-diagnose, and potentially Deadly Disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania... read more..

Sexually Transmitted Infections-Hormonal Contraceptives-Hormonal Contraception-Population Control

Depo Provera: English Guardian Aligns Itself With Neo-Eugenicist Policies

The English Guardian may face something of a dilemma when covering the WHO's failure to give clear advice to African women who have been persuaded to use Depo Provera and similar injectable Hormonal Contraceptives, which appear to be associated with a doubling of HIV transmission from females to males and from males to females; Birth Control is close to the heart of he who would control Population, Bill Gates, whose Foundation sponsors the paper's Global Development section. Not that the article appears in the Gates sponsored section; perhaps there is no such dilemma.
But Sarah Boseley sticks pretty close to the WHO's press release and says that women who use injectables such as Depo Provera should also use Condoms. As with the 'advice' from WHO, Boseley notes the use of 'dual protection' against pregnancy, on the one hand, and infection with sexually transmitted infections on the other. For Boseley and WHO, this means using condoms along with Depo Provera. But what neither seem willing to point out is that condoms on their own provide such dual protection.
So why would anyone want to use these expensive and possibly dangerous hormonal injections if condoms on their own give dual protection? Well, according to WHO and other 'experts' in reproductive health (often just a useful term for 'birth control'), condoms are not 'female controlled'; many people don't use condoms if they can help it. So rather than recommending that people who wish to avoid both pregnancy and sexually transmitted infections should use condoms, they recommend that people use Depo Provera, despite knowing that many people who opt for injectable hormonal contraceptives (and various other methods) cease to use condoms?
The oral versions of Depo Provera and similar contraceptives are said to be unsuitable because women need to take them daily and they may forget, or their husbands may object, etc. Injectable versions are said to be women controlled and only need to be taken every three months. In reality, they are to a large extent controlled by those who supply them, often NGOs and other institutions who believe strongly in the population control paradigm of development. Whatever synonyms are used, the concept of control is always detectable.
Boseley claims that women 'choose' Depo Provera and similar products but these pharmaceuticals are aggressively marketed by some of the biggest NGOs working in population control. Use of injectables has increased considerably over recent years but it's difficult to work out whether that's a matter of availability or genuine choice. Given the political and financial clout that NGOs and institutions such as the Gates Foundation have over the lives of people in developing countries, it seems unlikely that birth control is as high on the agenda of people in African countries as it is for the various non-African parties on the bandwaggon. One might even wonder if anyone gives a damn what Africans think about such matters.
It's astonishing just how uncritical Boseley is, in fact. She parrots bits about the WHO's 'expert group', but it was not concluded that hormonal contraception is safe ("Current evidence is not strong enough to prove or disprove an increased risk of HIV from hormonal contraception"). Rather, it has clearly been decided that it is safe enough for Africans and other poor people; it is not much used by white, middle-class Westerners. These products have not been shown to be safe, far from it. But the most important consideration for the WHO is that their goal of population control is not compromised by worries about safety issues, which they have been aware of for decades.
The logical conclusion to be drawn from the WHO's findings is that, if people want to avoid unplanned pregnancy and sexually transmitted infections, they should use condoms. The WHO statement is not based on a logical conclusion; it is a political declaration designed to protect the interests of Big Pharma read more..

Wednesday 18 April 2012

Brilliant Marketing-Merrell Road Glove-Shoe

Merrell Road Glove: AfnR's Bloggiest Shoe of the Week
Shoes
Bloggiest Shoe of the Week

I'm amused when I see multiple blog posts about a particular shoe appear across the Web within a short time period. It's kinda like a virtual trade show dedicated to one product. Brilliant marketing, really—not that I know anything about marketing.Anyway, since I'm not a presenter at this week's trade show, I'll assume the role of the unofficial directory. So, if you haven't seen all the Road Glove hoopla that kicked off yesterday, check out these links for photos and first-hand impressions:

  • Running, Rambling, and all-around-awesome blogger Donald writes an extensive Road Glove review with vibrant photos and a giveaway!
  • Barefoot Josh attests to the Road Glove's merits as a marathon shoe.
  • The barefoot superhero from Maple Grove promotes the Road Glove's functionality and incites public interest with a giveaway.
  • The folks at BirthdayShoes.com also present a convincing case for the Road Glove with superb photos.
  • (post-publication update) MinimalistRunningShoes decided to wait until Wednesday to join the show with a review of the Merrell Road Glove that glows so brightly my monitor nearly burst.
Of course, there were already a few reviews of the Road Glove on the web before this week. They appeared in September and October of 2011. So, this is probably phase two of the Merrell Road Glove, etc. Spring pre-release show. Good job keeping the line in our sights, Merrell.Now, how do I go about obtaining my own "test" pair of Merrel Road Gloves so that I can confirm or refute all the claims made in the posts linked above? Hmm.... read more..

Trail Running Shoes-Sticky Rubber-Differential

Inov-8 Trailroc 235, 245, and 255 Preview
Shoes
Inov-8 Trailroc 235, 245, and 255

A new range of trail running shoes from Inov-8 will tempt you in the Fall of 2012: The Trailroc™, a shoe boasting Inov-8's anatomic last, three Shoc-Zone™ options, and a uniquely designed outsole.

Trailroc Outsole

Like any good trail shoe, the outsole is the star feature here. And, the three cleat and rubber types comprising the Trailroc's outsole make for an interesting composition.Larger cleats made up of endurance rubber are placed in the high-wear areas, like under the ball of the foot. A hard, sticky rubber and more large cleats are positioned on the outer sections where grip and stability come into play most often. And, the toe and inner arch are comprised of a softer sticky rubber with smaller lugs.

Design Stuff

A couple of new design elements, changes to Inov-8's usual shoe upper construction and appearance, on the Trailroc caught my eye. And, even though you probably don't care about these minor design changes, I'll mention them. If I don't write about frivolous shoe minutiae, who will? Someone cares, right?So, for instance, the Shoc-Zone number now appears prominently on the lateral side at the base of the heel. This will undoubtedly help make the Inov-8 cushioning level system seem less enigmatic to new wearers of the brand. Fine.Also, from a lateral perspective, we see a few more wavy lines between the outsole and the upper. This differs from the rather simplistic, relatively lineless motif of previous Inov-8 shoes. In fact, the numerous lines in the midsole almost make me wonder how much cushion actually exists in their ZERO differential 235 member of the Trailroc range. See what I mean in the photo below from Natural Running Store.A more subtle display of the Inov-8 logo adds a new dimension to this range of shoes. I've always marveled at the rather conspicuous presentation of the logo on previous models, like the f-lite 230. Does a smaller logo indicate more brand confidence? I dunno. And, I'm sure none of you really care.Also noteworthy, I think, is the pull loop on the heel cup area. I mean, it's relatively large for an Inov-8 heel-pull-loop thingie. Will we complain about its aesthetic appeal when we look at the Trailroc in photos? Maybe. Will we notice it after putting on our Trailrocs? No. Again, this is a design feature that I'm only mentioning because I notice stuff that most people don't even think about.

Three Variations on Minimal

Since the Trailroc Shoc-Zone variations are being announced at one time I believe that these three shoes will be made available all at one time, too, next year. That's only logical, right? This is good. Having three options from which to choose all at once is better than buying one option before learning about a forthcoming more/less minimal option that you would have preferred in the first place. So, the Trailroc range of options are:
  • the 255 with a Shoc-Zone 2 (6mm differential)
  • the 245 with Shoc-Zone 1 (3mm differential)
  • the 235 with Shoc-Zone ZERO - 0mm differential)
I'm most intrigued by the 235, because, despite my penchant for my f-lite 230s, I've developed an affinity for shoes with a zero differential. But, the 235 is heavier than my other "minimal" trail shoes. Why? According to Inov-8, their ZERO Shoc-Zone shoes have no midsole. So, perhaps the outsole compounds are just that much heavier. I guess I'll just have to find out when I find out.

So...

I'm excited about these shoes.Apparently less luggy than the Bare-Grip 200 or X-Talon 190, but more grippy than the f-lites, the Trailroc looks as though it will be a great all-around trail shoe for my East-Coast terrain, much like the Roclites. It's significant that the Trailroc will feature the fantastic anatomic last, something I've been enjoying immensely while wearing the Bare-X Lite 150 on road runs. And my toes are more likely to prefer the anatomic last to the Roclite's performance last on longer runs. So, the comfy anatomic last, coupled with the fact th read more..

Thursday 5 April 2012

Aids Healthcare Foundation-Yeghiayan Friedman-Ahf

By Lori Yeghiayan FriedmanAIDS Healthcare Foundation recently...

By Lori Yeghiayan FriedmanAIDS Healthcare Foundation recently brought its expert brand of HIV/AIDS services to the people of the deep South when one of its AHF “Magic Johnson” mobile testing units arrived on the steps of the Capitol in Jackson, Mississippi.
The services showcased by AHF were just a preview of coming attractions. Within the year, AHF will open an AHF Healthcare Center, as well as an AHF Pharmacy and HIV testing facility in Jackson. In addition, the group—the largest global AIDS organization—will operate a mobile unit, serving Jackson and the surrounding areas, in order to provide services to hard to reach populations.More info on this story at www.aidshealth.org. read more..

Receptor Molecule-Hot Chili Pepper-Mechanisms-Pain

An airbag for perceiving pain: Basic mechanisms governing the perception of pain discovered

Everyone knows how it feels to bite into a hot chili pepper or burn the roof of one’s mouth with a hot drink. This activates nerve cells that relay the potential threat to the brain, which then causes the person in question to perceive Pain. Over 14 years ago, researchers discovered the first receptor molecule that reacts to heat as well as to capsaicin, the active substance in chili extracts. At the time it was believed that science had come a big step closer to understanding the emergence of pain and its treatment with medicine. The disappointment was great when it was found several years later that laboratory mice from whom the gene of this receptor had been artificially removed still perceived pain. Despite repeated attempts to explain the causes of this observation, it has remained a mystery until now. Researchers have now deciphered basic mechanisms governing the perception of pain. read more..

Sunday 1 April 2012

Conference On Retroviruses-Opportunistic Infections-Antiretroviral Therapy-Internet Symposium

Fast online review of antiretroviral advances at CROI, March 3

ViralEd: "This 1.5-hour live Internet symposium will review and discuss the key studies on antiretroviral therapy presented at the 18th Conference on Retroviruses and Opportunistic Infections. The symposium will feature five well-known and recognized thought leaders in the HIV field, with four serving as presenting faculty/discussants and one as program moderator."Comment (JSJ): There will be many reviews of the important Conference on Retroviruses and Opportunistic Infections (CROI) in Boston (Feb. 27 - March 2), most of them weeks or months later. This review has 5 top experts -- and happens on March 3, the day after the conference ends. It's free online for anyone, but you need to preregister.I'm attending CROI, but will also watch this summary on the antiretroviral therapy advances presented there. read more..